Inventor · disambiguated record
Qing Zhou
Also filed as: ZHOU QING · ZHOU QING-WEI
10 granted patents·15 pending applications·66 citations·filing 2000–2024
86Inventor score
Files withMEDIMMUNE LTD4SHANGHAI ESCUGEN BIOTECHNOLOGY CO LTD4CENTRE FOR NOVOSTICS3CENTRE FOR NOVOSTICS LTD2GENOR BIOPHARMA CO LTD2
Top patents by PatentIndex Score
25 records- 0195US7973140B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2005·Granted Jul 5, 2011·36 cites·11 claims
- 0285US8119130B2Targeted binding agents directed to KDR and uses thereof—035BARRY SIMON THOMAS·Filed 2008·Granted Feb 21, 2012·14 cites·4 claims
- 0384US8834880B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2012·Granted Sep 16, 2014·5 cites·4 claims
- 0481US8026344B2Targeted binding agents directed to uPAR and uses thereofMEDIMMUNE LTD·Filed 2007·Granted Sep 27, 2011·6 cites·18 claims
- 0578US10066011B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2014·Granted Sep 4, 2018·2 cites·15 claims
- 0675US9896510B2Anti-human RANKL antibody, humanized antibody of the same, and pharmaceutical composition and use thereofZHOU QING·Filed 2015·Granted Feb 20, 2018·3 cites·21 claims
- 0766US2023366007A1Analysis of nucleic acids associated with extracellular vesiclesCENTRE FOR NOVOSTICS LTD·Filed 2023·Application pending·0 cites
- 0864US2025171858A1Enrichment of clinically-relevant nucleic acidsCENTRE FOR NOVOSTICS·Filed 2024·Application pending·0 cites
- 0964US2023313314A1Fragmentation for measuring methylation and diseaseCENTRE FOR NOVOSTICS LTD·Filed 2023·Application pending·0 cites
- 1062US2024287593A1Single-molecule strand-specific end modalitiesCENTRE FOR NOVOSTICS·Filed 2024·Application pending·0 cites
- 1161US12258634B2Fragmentation for measuring methylation and diseaseCENTRE FOR NOVOSTICS·Filed 2023·Granted Mar 25, 2025·0 cites·26 claims
- 1258US2024082415A1Antibody-drug conjugates (adcs) comprising an anti-trop-2 antibody, compositions comprising such adcs, as well as methods of making and using the sameLEVENA SUZHOU BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1354US12435135B2Human CD47-targeting single-domain antibody and use thereofSHANGHAI ESCUGEN BIOTECHNOLOGY CO LTD·Filed 2021·Granted Oct 7, 2025·0 cites·23 claims
- 1454US2012052073A1Antibodies Directed to Angiopoietin-2 And Uses ThereofGREEN LARRY L·Filed 2011·Application pending·0 cites
- 1551US2010196398A1Targeted binding agents directed to cd105 and uses thereofMEDIMMUNE LLC·Filed 2009·Application pending·0 cites
- 1648US2025268939A1Chimeric Antigen Receptor Molecule for Specifically Recognizing Baff-R and Application of Chimeric Antigen Receptor MoleculeSHANGHAI ESCUGEN BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 1742US10017555B2Long-acting blood sugar decreasing fusion proteinGENOR BIOPHARMA CO LTD·Filed 2014·Granted Jul 10, 2018·0 cites·14 claims
- 1842US2012108797A1Targeted binding agents directed to upar and uses thereofELVIN PAUL·Filed 2011·Application pending·0 cites
- 1941US2023096452A1Claudin 18.2 antibody and use thereofSHANGHAI ESCUGEN BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 2041US2014302055A1Antibodies Directed to Angiopoietin-like Protein 4 and Uses ThereofZHONG HAIHONG·Filed 2012·Application pending·0 cites
- 2141US2004191850A1Nucleic acid molecules encoding proteins essential for plant growth and development and uses thereofSYNGENTA PARTICIPATIONS AG·Filed 2003·Application pending·0 cites
- 2240US2023312704A1Cldn18.2 antibody and use thereofSHANGHAI ESCUGEN BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 2336US2003148950A1Kringle domain 1 of human hepatocyte growth factor and uses thereforFiled 2002·Application pending·0 cites
- 2434US10253108B2Mutated antibody of fully humanized HER2 antibody, and encoding gene and use thereofGENOR BIOPHARMA CO LTD·Filed 2015·Granted Apr 9, 2019·0 cites·12 claims
- 2533US2002157142A1Herbicide target genes and methodsFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qing Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →